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The adherence to therapy associated with the socio-demographic variables and the habits of patients 
with hypertension and/or diabetes mellitus were investigated in this study. The registration forms of 
105 patients in the Hiperdia program in the municipality of Campina Grande-PB were used as a data 
collection instrument, applying the Morisky-Green test (MGT) and Batalla test (BT) to assess compliance 
treatment. For the MGT, there was a prevalence of non-adherent individuals (76.2%) and the type of 
predominant behavior was unintentional. The internal consistency of the responses obtained through the 
MGT presented good reliability, according to the value of 0.69 obtained by Cronbach’s alpha. For the BT, 
there was a predominance of adherence (68.6%) and the alpha value was 0.80, showing a high reliability 
level. It was found that a diet lacking in salt is a strong impact variable for determining the adherence to 
the BT. Given the representativity of the tests, there is a need to amend the interferences that facilitate 
the low adherence to drug treatment. The results of this study can be used to construct strategies that will 
address these difficulties and optimize the adherence level and quality of life of patients.
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INTRODUCTION 
The prevalence of hypertension and diabetes 
mellitus (DM) has increased worldwide, especially in low- 
and middle-income countries. In a report, the World Health 
Organization (WHO, 2012) highlighted the growing 
problem of the increase in non-communicable diseases and 
showed that about 30% of the world population presents 
hypertension and 10% presents DM. 
In Brazil, hypertension presents itself as a serious 
public health problem due to its high prevalence, affecting 
between 15% and 20% of the adult population and more 
than 50% of the elderly (Carvalho Filha, Nogueira, Viana, 
2011; Strelec, Pierin, Mion, 2011). As most of its course 
is asymptomatic, its diagnosis and treatment are often 
neglected; in addition, therapeutic adherence tends to be 
low, which results in an inadequate control of hypertension 
(Ministry of Health of Brazil, 2006).
DM is one of the major public health diseases 
in Brazil. Its incidence and prevalence are increasing 
in epidemic proportions, reaching a 7.6% prevalence 
in a national study carried out in various capital cities. 
It is associated with complications that compromise 
productivity, quality of life, and survival of individuals 
(Barros, Rocha, Helena, 2008).
The Ministry of Health (MS) of Brazil has created 
numerous programs to control diseases with the greatest 
impact on the population. In the case of hypertension 
and DM, the MS has implemented the National Program 
of Hypertension and Diabetes Mellitus – Hiperdia. This 
program promotes the reorientation of pharmaceutical 
assistance by providing a continuous and free supply of 
medicine, in addition to monitoring the clinical conditions 
of each user (Carvalho et al., 2012; Ministry of Health of 
Brazil, 2001).
In this approach, an aspect of the treatment of these 
diseases has been given great importance: adherence 
to treatment. Accession corresponds to the agreement 
among the medical prescription and the patient’s conduct, 
as it is a predominant reason for concern in the control 
of hypertension and DM. However, a large portion of 
hypertensive and diabetic people do not use the drugs 
properly or change their routines and physical activity to 
control such diseases, which can sometimes manifest with 
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or without symptoms (Girotto, 2008; Figueiredo et al., 
2001).
In chronic diseases, whose treatment demands the 
continuous use of medicines, patient adherence to the 
prescribed drug regimen is essential (Dewulf et al., 2006). 
Lack of treatment compliance by patients with 
hypertension and/or DM is common and associated with 
many factors, such as difficulty following the treatment, 
financial difficulties, adverse effects of drugs, difficulty 
accessing healthcare, the inadequacy of the doctor-patient 
relationship, as well as the very characteristics of the 
disease, which usually presents itself as asymptomatic 
in the first 15 to 20 years, in addition to its chronicity 
(Girotto, 2008; Busnello et al., 2001).
This study aimed to investigate the adherence to 
therapy associated with sociodemographic data and the 
lifestyle of patients with hypertension and/or DM.
METHODS
Study design
This is descriptive research with a quantitative 
approach of the documental type. It was carried out from 
January to June 2015 in the Family Health Strategy (FHS) 
Galante I and II, municipality of Campina Grande, state 
of Paraíba, Brazil.
Study population and methodology used
We selected 105 participants in accordance with the 
criteria for inclusion and exclusion. 
All patients of the local Hiperdia program who agreed 
to participate in the survey were included by signing the 
Terms of Consent (TFCC). Exclusion criteria were: patients 
aged < 18 years, illiteracy, and cognitive deficits.
To assess adherence to the pharmacological 
treatment, two standardized tests were used: the Morisky-
Green Test (MGT) and the Batalla Test (BT). The 
two tests are standardized, characterized as indirect 
evaluation instruments through self-report. The MGT is 
a scale composed of four questions, as shown in Table I. 
According to the original MGT, respondents are classified 
in only two groups: adherents or non-adherents. Adherents 
are considered individuals who answer all questions 
correctly and earn four points, and non-adherents are those 
who obtain three points or less (Morisky, Green, Levine, 
1986; Strelec, Pierin, Mion, 2003).
This research, in addition to the original classification 
adopted by the MGT, has applied a proposal presented 
by Medeiros (2006), who suggested the adoption of 
a reclassification into three subgroups to characterize 
adherence to drug treatment based on the number of points 
obtained on the MGT: low = 0 or 1 point; moderate = 2 
or 3 points; high adherence = 4 points, to better assess the 
individual components of the MGT. 
The BT, which measures adherence through the 
participants’ knowledge about their disease, is composed 
of three questions (Carvalho, Nogueira, Viana, 2011). In 
this study, in accordance with the BT, the questions were 
asked as follows: 1st: “Are hypertension and DM diseases 
for life?” 2nd: “Can you control the hypertension and the 
DM with diet and/or medication?” 3rd: “Cite two or more 
organs that may suffer injuries by hypertension or DM.” 
The questions were directed in relation to the type of 
disease presented by the user. The BT considers patients’ 
to be adherent if they answer the three questions correctly.
Data collection 
To evaluate the sociodemographic and economic 
variables (age, gender, occupation, retired, monthly family 
income, education, marital status, number of persons 
residing in the house) and life habits (non-communicable 
chronic diseases [NCCD], heredity, alcoholism, smoking, 
diet lacking in salt, exercising), the records of registration 
and tracking of the patients of the program Hiperdia were 
analyzed.
Data analysis
Data were typed and handled in Microsoft Excel 
(2010) and SPSS 17.0 (SPSS, Inc. 2008). Quantitative 
analysis of the data was made by calculating frequency 
distributions and percentages. For decision making in 
FIGURE 1 - Questions that make up the MGT and classification 
regarding the intention of the types of low adherence behavior 
(Adapted from Morisky, Green, Levine, 1986).
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relation to data, we sought to test the internal homogeneity 
of the variables and independence among them using the 
Chi square (c2) statistical test or Fisher Exact Test. The 
results were considered significant when the significance 
level (p) was less than 0.01. 
As a statistical tool to quantify the reliability of the 
questionnaire the Cronbach’s alpha test was used. The 
minimum acceptable value for alpha is 0.70, on a scale 
from 0 to 1 (Streiner, 2003).
Ethical aspects
The project was approved by the Ethics Research 
Committee in research involving humans at the 
State University of Paraíba, through opinion No. 
34912814.0.0000.5187.
RESULTS
According to Table I, we verified that of the 
105 patients interviewed, most of them were female 
(74.3%), adults (53.3%), ranged in age from 26 to 83 years 
with an average of 58.27 ± 12.52 years, married (68.6%), 
pensioners (53.3%), and had a monthly family income 
in the range of 1 to 3 times the minimum wage (86.7%). 
The most common occupations were farmer (50.5%) and 
housewife (27.6%). The most prevalent level of education 
was incomplete primary education (51.4%). With 
respect to the number of human residents per household, 
we obtained an average of 3.43 (± 1.53). Regarding 
diseases, hypertension, and/or DM, it was observed that 
81 participants (77.1%) had only hypertension, 4 (3.8%) 
had only diabetics, and 20 (19%) had both morbidities. 
Research on smoking and alcoholism habits of the 
patients showed that there was a prevalence of participants 
who reported not to be smokers (93.3%) or intake alcoholic 
beverages (89.5%). We identified that a predominance 
of participants, a total of 62 (59.0%), possessed the 
hereditary factor for developing hypertension and/or 
DM. Regular physical exercise and a diet lacking in salt 
(NaCl) were also analyzed. We identified that 69 (65.7%) 
of the participants are sedentary and do not have a habit of 
regular physical exercise. As to the implementation of the 
recommendation of a diet lacking in salt, this eating plan 
was observed in 58 (55.2%) patients (Table I).
The Chi Square test of adherence (Table I) 
presented a p-value greater than 0.01 for the salt 
diet variable, suggesting that there are no significant 
TABLE I - Distribution of sociodemographic and economic variables of Hiperdia users (Applying the Chi Square analysis of 
variables adherence).
Variables Quantities % Test p-value Analysis
Age (years)
Between 20 and 59 56 53.3% c2 0.495 NS1
≥ 60 49 46.7%
Gender 
Masculine 27 25.7% c2 0.001 AS2
Feminine 78 74.3%
Occupation/Profession
Farmer 53 50.5% c2 - -
Housewife 29 27.6%
Other 23 21.9%
Retired
Yes 56 53.3% c2 0.467 NS
No 49 46.7%
Monthly household income (n. minimum wages)
Less than 1 minimum wage 9 8.6% c2 0.001 AS
Between 1 and 3 minimum wages 91 86.7%
More than 3 minimum wages 5 4.7%
Education
Incomplete primary education 54 51.4% c2 0.001 AS
Complete primary education 29 27.6%
Incomplete high school 9 8.6%
Complete high school 13 12.4%
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Variables Quantities % Test p-value Analysis
Marital Status
Single 15 14.3% c2 0.0001 AS
Married 72 68.6%
Widower 10 9.5%
Divorced/Separated 6 5.7%
Other 2 1.9%
Number of persons residing in the house - - -
1 (1) 6 5.7% c2 0.0001 AS
2 to 3 (2) 54 51.4%
4 to 5 (3) 38 38.0%
6 to 8 (4) 7 6.7%
Non-communicable chronic diseases
Hypertension 81 77.1% c2 0.0001 AS
Diabetes Mellitus 4 3.8%
Hypertension and Diabetes Mellitus 20 19.0%
Heredity
Yes 62 59.0% c2 0.064 NS
No 43 41.0%
Alcoholism 
Yes 11 10.5% c2 0.0001 AS
No 94 89.5%
Smoking
Yes 7 6.7% c2 0.0001 AS
No 98 93.3%
Physical exercise
Yes 36 34.3% c2 0.001 AS
No 69 65.7%
Salt diet
Yes 58 55.2% c2 0.283 NS
No 47 44.8%
1 NS: Non-Asymptotic Test, where p > 0.01. 2 AS: Asymptotic Test, where p > 0.01.
TABLE I - Distribution of sociodemographic and economic variables of Hiperdia users (Applying the Chi Square analysis of 
variables adherence) (cont.)
differences between categories; this is concerning, given 
that only 55.2% of participants adopted a diet lacking in 
salt, while all patients suffering of hypertension and/or 
DM require a high level of accession with respect to this 
recommendation. 
Using the MGT original classification criterion, only 
24 participants were considered to be adherent. 
Considering the proposal of Medeiros (2006) to 
reclassify the interviewed patients into three groups by the 
MGT, 25 patients (23.8%) were classified as a group with a 
high level of accession, 65 (61.9%) as medium accession, 
and only 15 (14.3%) participants fell within the range of 
low accession.
When observing the patients’ answers in detail to the 
four questions of the MGT, the most negative responses 
referred to Questions 1 and 2, reaching values of 59.0% 
and 41.0%, respectively, according to Figure 2.
The internal consistency of the responses obtained 
through the MGT showed that this measuring instrument 
FIGURE 2 - Individual examination of the MGT (Morisky-Green 
test) questions, showing the percentage of negative responses 
obtained in the interview.
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showed good reliability, according to the Cronbach’s 
alpha value of 0.69.
As for the results of the BT, which addresses the 
respondents’ knowledge level about their conditions, it 
was found that 72 (68.6%) were considered to be adherent, 
while only 33 (31.4%) were classified as nonadherent. 
According to the Cronbach’s alpha value (0.80), the 
results showed high reliability. 
In the analysis of sociodemographic variables 
(age, gender, occupation/ profession, retired, monthly 
income, education, marital status, and number of people 
residing in the house) and lifestyle (NCCD, heredity, 
alcohol consumption, smoking, exercise, and salt diet) 
as possible interfering factors in adherence to drug 
treatment, according to MGT, there was no significant 
association between them and adherence (p>0.01), this is, 
the variables are independent, as shown in Table II. 
However, in the analysis of the variables as possible 
confounders in adherence to drug treatment, according to 
BT (Table III), the variable “Salt Diet” presented a p-value 
lower than 0.01, suggesting an association between 
the variables. Analyzing the contingency coefficient, a 
correlation of 23.2% was shown between the variables, 
which is considered low.
Regarding the third question of BT, which seeks to 
find out if the user knows the organs that can be affected 
by uncontrolled hypertension and/or DM, this study found 
that the most cited organs were: heart, kidneys, brain, and 
eyes.
DISCUSSION 
The analysis of socioeconomic characteristics 
features individuals as being predominantly low-income 
and socially excluded, and that the public health services 
in primary health care are directed to this part of society; 
this corroborates with Assis, Villa and Nascimento (2003) 
as well as demonstrates that the population served by the 
TABLE II - Distribution of sociodemographic and economic variables of Hiperdia users to analyze the association between the 
variables and adherence to MGT
Variables Adherence-MGT % p-value Test
Age (years)
Between 20 and 59 15 25.0% 0.373 c2
≥ 60 10 20.4%
Gender 
Masculine 9 34.6% 0.1 c2
Feminine 16 19.0%
Occupation/Profession
Farmer - - - -
Housewife - -
Other - -
Retired
Yes 11 19.6% 0.272 c2
No 14 26.5%
Monthly household income (n. minimum wages)
Less than 1 minimum wage 4 36.4% 0.235 Fisher
Between 1 and 3 minimum wages 19 20.2%
More than 3 minimum wages 2 40.0%
Education
Incomplete primary education 16 27.3% 0.276 Fisher
Complete primary education 3 10.7%
Incomplete high school 3 33.3%
Complete high school 3 23.1%
Marital Status
Single 0 0.0% 0.08 Fisher
Married 19 25.4%
Widower 4 36.4%
Divorced/Separated 2 33.3%
Other 0 0.0%
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Variables Adherence-MGT % p-value Test
Number of persons residing in the house
1 (1) 1 16.7% 0.54 Fisher
2 to 3 (2) 14 24.5%
4 to 5 (3) 7 17.9%
6 to 8 (4) 3 42.9%
Non-communicable chronic diseases
Hypertension 16 18.5% 0.105 Fisher
Diabetes Mellitus 1 25.0%
Hypertension and Diabetes Mellitus 8 40.0%
Heredity
Yes 13 19.4% 0.305 c2
No 12 27.9%
Alcoholism
Yes 1 9.1% 0.45 Fisher
No 24 24.5%
Smoking
Yes 3 42.9% 0.194 Fisher
No 22 21.4%
Physical exercise
Yes 7 19.4% 0.547 c2
No 18 24.6%
Salt diet
Yes 10 17.2% 0.099 c2
No 15 29.8%
TABLE II - Distribution of sociodemographic and economic variables of Hiperdia users to analyze the association between the 
variables and adherence to MGT (cont.)
TABLE III - Distribution of sociodemographic and economic variables of Hiperdia users to analyze the association between the 
variables and adherence to BT
Variables BATALLA p-value TestAdherence Non Adherence
Age (years)
Between 20 and 59 17 (30.4%) 39 (69.6%) 0.8 c2
≥ 60 16 (32.7%) 33 (87.3%)
Gender 
Masculine 8 (30.8%) 18 (69.2%) 0.933 c2
Feminine 25 (31.6%) 54 (68.4%)
Occupation/Profession
Farmer - - - -
Housewife - -
Other - -
Retired
Yes 19 (33.9%) 37 (38.4%) 0.555 c2
No 14 (28.6%) 35 (71.4%)
Monthly household income (n. minimum wages)
Less than 1 minimum wage 4 (36.4%) 7 (63.6) 0.908 Fisher
Between 1 and 3 minimum wages 28 (31.5%) 61 (68.5%)
More than 3 minimum wages 1 (20%) 4 (80%)
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Variables BATALLA p-value TestAdherence Non Adherence
Education
Incomplete primary education 22 (40%) 33 (60%) 0.08 Fisher
Complete primary education 8 (28.6%) 20 (71.4%)
Incomplete high school 0 9 (100%)
Complete high school 3 (23.1%) 10 (76.9%)
Marital Status
Single 7 (46.7%) 8 (53.3%) 0.238 Fisher
Married 24 (33.8%) 47 (66.2%)
Widower 1 (9.1%) 10 (90.9%)
Divorced/Separated 1 (16.7%) 5 (83.3%)
Other 0 2 (100%)
Number of persons residing in the house
1 (1) 1 (16.7%) 5 (83.3%) 0.229 Fisher
2 to 3 (2) 14 (26.4%) 39 (73.6%)
4 to 5 (3) 17 (43.6%) 22 (56.4%)
6 to 8 (4) 1 (14.3%) 6 (85.7%)
Non-communicable chronic diseases
Hypertension 29 (35.8%) 52 (64.2%) 0.255 Fisher
Diabetes Mellitus 0 4 (100%)
Hypertension and Diabetes Mellitus 4 (20%) 16 (80%)
Heredity
Yes 16 (25.8%) 46 (74.2%) 0.199 c2
No 17 (39.5%) 26 (60.5%)
Alcoholism
Yes 3 (27.3%) 8 (72.7%) 0.526 Fisher
No 30 (31.9%) 64 (68.1%)
Smoking
Yes 2 (28.6%) 5 (71.4%) 0.616 Fisher
No 31 (31.6%) 67 (68.4%)
Physical exercise
Yes 15 (41.7%) 21 (58.3%) 0.103 c2
No 18 (26.1%) 51 (73.9%)
Salt diet
Yes 24 (41.4%) 34 (58.6%) 0.01 X2
No 9 (19.1%) 38 (80.9%)
TABLE III - Distribution of sociodemographic and economic variables of Hiperdia users to analyze the association between the 
variables and adherence to BT (cont.)
Hiperdia program has a high dependence on the National 
Health System (Health Unic System - HUS) and exhibits 
high social vulnerability. 
 The mere 55.2% of patients who adopt a diet 
lacking in salt is worrisome, because patients suffering 
from hypertension and/or DM require a high level of 
compliance in relation to this recommendation. 
According to the MGT, the adherence results 
of only 24% of patients demonstrated a low level of 
pharmacological treatment adherence, taking into 
consideration that the recommended percentage is at least 
80%, according to Carvalho et al. (2012). Similar results 
were found by Eid et al. (2013), in which a predominance 
of non-adherence to treatment was observed. 
Taking into consideration the proposal of Medeiros 
(2006) for the MGT, a prevalence of patients classified 
as the medium adherence group was identified. As such, 
a greater individual analysis of the four components of 
the MGT is necessary, with the purpose of observing the 
influence of each factor for adherence.
Through the analysis of Figure 2, it is clear that, 
for MGT, the main factors that negatively contributed to 
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poor adherence were unintentional characteristics, such 
as forgetfulness and carelessness in taking medication, 
corroborating with other studies (Carvalho et al., 2012; 
Dunbar-Jacob, Mortimer-Stephens, 2001; Kane et al., 
2003; Sewitch et al., 2003) in which these behaviors 
were often responsible for the low level of compliance. 
According to Morisky, Green, and Levine (1986), these 
factors are resolve when compared to intentional attitudes. 
The analysis of Cronbach’s alpha (0.69) to MGT 
provides a reliability test of the results obtained, giving 
greater relevance and robustness to the research. 
For the BT, 68.6% of the participants were adherent, 
demonstrating that they possess a considerable of 
knowledge about their disease. Inconsistent results for the 
BT have been found in a study by Carvalho et al. (2012), 
in which a prevalence of non-adherence among Hiperdia 
patients was observed. Regarding the BT, the value of 
Cronbach’s alpha of 0.80 reveals a high level of reliability.
By confronting the adherence rates found in 
this study to the MGT and BT, we identified a large 
discrepancy, with a prevalence of non-adherence of 
76% for MGT, while in BT there was an adherence 
predominance of 68.6%. This variation in results between 
tests can be explained by their different approach to 
evaluating adherence. In the MGT, the attitudes of 
the individuals facing the administration of medicines 
are examined, while the BT observes the participants’ 
knowledge about their illnesses. 
This study noted that patients who have DM (n=24) 
present a discrete increase in rates of adherence to drug 
treatment for the MGT and BT. This can be explained 
due to complications of DM being usually more severe 
and noticeable when compared to the evolution of the 
hypertension, which often remains silent. With respect to 
the BT, diabetic patients showed a high adherence (87%). 
However, for the MGT, a low adherence (39.1%) was 
identified. Therefore, regardless of the type of chronic 
disease, this study noted a discrepancy in relation to the 
adherence of patients in both tests, with a predominance of 
non-adherence in the MGT and a prevalence of adherence 
in the BT.
The study shows the big challenge of hypertension 
and DM control, predominantly in elderly patients. 
Given the multifactorial and complex character of these 
chronic diseases, it is necessary to think about solutions 
to the difficulties reported by respondents and to intensify 
actions to strengthen and educate the carrier population 
and promote the importance of treatment adherence and 
changes in lifestyle. 
CONCLUSION
The evaluation and conscientization of chronic 
disease carriers must evolve, aiming at a greater 
adherence to both prescribed pharmacological and non-
pharmacological treatments. In addition, further studies 
are needed with other methods that better characterize 
the factors that are contributing to the low adhesion. The 
multi-professional team of the family health strategy needs 
to improve its actions and collective programs seeking 
the excellence in the services rendered, guaranteeing an 
improved individual assistance.
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